VACCINE JAPANESE ENCEPHALITIS, monodose, 6µg/0.5ml syr.
STD
DVACVENC1S-
Valid Article
Account code:
60010
HS Code:
300241
Last Updated on:
07/11/2024, 20:40:01
Former
Code(s):
-X
19.3 - Vaccines
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J07BA02
Anatomical Therapeutic Chemical Classification according to WHOCC
OC subscriptions: included in supply or field order tools (e.g. UniField)
|
|
SC subscriptions: included in supply or field tools
|
|
OC validations: approved for procurement and use by an OC for international or local orders specifying context and activity in Medical Standard Lists (MSL)
|
|
VACCINE JAPANESE ENCEPHALITIS
Therapeutic Action
Purified inactivated Japanese encephalitis virus vaccine
Indications
Prevention of Japanese encephalitis
Japanese Encephalitis is endemic in specific regions (Southeast and Southwest Asia, Western Pacific).
Some restricted information has been hidden. Sign in
to see this information
Instructions for use
Pre-filled syringe for single use
Suspension in liquid form
Shake the syringe before use to homogenise the suspension. Do not administer if particles remain after shaking or if any discolouration is observed.
Must be given by IM route, preferably into the deltoid muscle.
Precautions for Use
Do not administer in children under 1 year of age.
As with all injectable vaccines and/or immunoglobulins, appropriate medical treatment should always be readily available in case of rare anaphylactic reactions following the administration of the product.
Storage
- Keep refrigerated between 2°C and 8°C - Protect from sunlight
- Do not freeze.